In collaboration with AbbVie Ltd, Picker’s survey for patients with moderate-severe atopic dermatitis, hidradenitis suppurative and psoriasis, is designed to understand access to and experiences of care and treatment. Findings following development have already been used to make recommendations for commissioners, healthcare professionals, patient support groups and patients.
The survey covers:
- Communication and information with involvement in decisions;
- opportunity to discuss treatment options; and
- quality of life.
The survey covers care from a GP and a dermatologist, and is available to providers of skin conditions (dermatitis, HS and psoriasis) to licence. It enables an understanding of patient experiences of care and quality of life, creating insights that can be used to improve care quality.